NCT05546658View on ClinicalTrials.gov

Effects of Psilocybin in Obsessive Compulsive Disorder

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 28, 2022

Primary Completion Date

September 12, 2026

Study Completion Date

September 12, 2027

Conditions
Obsessive-Compulsive Disorder
Interventions
DRUG

Psilocybin

Psilocybin administration under supportive conditions

Trial Locations (1)

21224

RECRUITING

Johns Hopkins University School of Medicine, Baltimore

All Listed Sponsors
collaborator

Usona Institute

OTHER

lead

Johns Hopkins University

OTHER